Zobrazeno 1 - 10
of 200
pro vyhledávání: '"A. V. Kristen"'
Autor:
Nerea Mora-Ayestaran, MD, Angela Dispenzieri, MD, Arnt V. Kristen, MD, Mathew S. Maurer, MD, Igor Diemberger, MD, Brian M. Drachman, MD, Martha Grogan, MD, Pritam Gupta, PhD, Oliver Glass, PhD, Leslie Amass, PhD, Pablo Garcia-Pavia, MD, PhD, Michele Emdin, Mazen Hanna, Olga Azevedo, Calogero Lino Cirami, Jose Gonzalez Costello, David Slosky, Henning Moelgaard, Jose Nativi Nicolau, Scott Hummel, Eun-Seok Jeon, Nowell Fine, Srinivas Murali, Edward Miller, Sanjiv Shah, Ronald Witteles, Marcia Waddington-Cruz, Daniel Lenihan, Yoshiki Sekijima, Johan Van Cleemput, Edileide de Barros Correia, Eve Cariou, Dianna Quan, Miriam Freimer, David Steidley, Anna Hüsing-Kabar, Violaine Plante-Bordeneuve, Hans Nienhuis, Jonas Wixner, Jeffrey Ralph, Hector Ventura, Sasa Zivkovic, Diego Delgado, Roberto Fernandéz Torrón, Stephen Gottlieb, William Cotts, Jose Tallaj, Robert Brunkhorst, Michael Polydefkis, Christopher Mueller, Carsten Tschoepe, Juan Gonzalez Moreno, Nitasha Sarswat, Jin Luo, James Tauras, Alberta Warner
Publikováno v:
JACC: Advances, Vol 3, Iss 8, Pp 101086- (2024)
Background: Wild-type transthyretin amyloidosis (ATTRwt amyloidosis) is primarily diagnosed in elderly men but diagnoses in younger patients and women have recently increased. Objectives: The purpose of this study was to examine age- and sex-related
Externí odkaz:
https://doaj.org/article/dc542adf430b4e7fb29d0bce4d17c600
Autor:
Luca Gentile, Igor Diemberger, Violaine Plante-Bordeneuve, Anna Mazzeo, Amir Dori, Marco Luigetti, Andrea Di Paolantonio, Angela Dispenzieri, Martha Grogan, Márcia Waddington Cruz, David Adams, Jocelyn Inamo, Arnt V Kristen, Calogero Lino Cirami, Doug Chapman, Pritam Gupta, Oliver Glass, Leslie Amass
Publikováno v:
PLoS ONE, Vol 19, Iss 1, p e0292435 (2024)
Transthyretin amyloidosis (ATTR amyloidosis) is a progressive, multi-systemic disease with wild-type (ATTRwt) and hereditary (ATTRv) forms. Over 130 variants associated with ATTRv amyloidosis have been identified, although little is known about the m
Externí odkaz:
https://doaj.org/article/b4835a69d68c421cbbe3db9d170e24ee
Autor:
Fabian aus dem Siepen, Selina Hein, Eva Hofmann, Christian Nagel, Stéphanie K. Schwarting, Ute Hegenbart, Stefan O. Schönland, Markus Weiler, Norbert Frey, Arnt V. Kristen
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 8, p 2257 (2024)
Introduction: Cardiac transthyretin amyloidosis (ATTR) is a progressive, fatal disease leading to heart failure due to accumulation of amyloid fibrils in the interstitial space and may occur as a hereditary (ATTRv) or wild-type (ATTRwt) form. Guideli
Externí odkaz:
https://doaj.org/article/8d2c62e0ecc84a39858b681fea7d68e3
Autor:
Angela Dispenzieri, Teresa Coelho, Isabel Conceição, Márcia Waddington-Cruz, Jonas Wixner, Arnt V. Kristen, Claudio Rapezzi, Violaine Planté-Bordeneuve, Juan Gonzalez-Moreno, Mathew S. Maurer, Martha Grogan, Doug Chapman, Leslie Amass, the THAOS investigators
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-12 (2022)
Abstract Background Transthyretin amyloidosis (ATTR amyloidosis) is a rare, life-threatening disease caused by the accumulation of variant or wild-type (ATTRwt amyloidosis) transthyretin amyloid fibrils in the heart, peripheral nerves, and other tiss
Externí odkaz:
https://doaj.org/article/9781169f9482467fa0d76aa446549e0d
Autor:
Morie Gertz, David Adams, Yukio Ando, João Melo Beirão, Sabahat Bokhari, Teresa Coelho, Raymond L. Comenzo, Thibaud Damy, Sharmila Dorbala, Brian M. Drachman, Marianna Fontana, Julian D. Gillmore, Martha Grogan, Philip N. Hawkins, Isabelle Lousada, Arnt V. Kristen, Frederick L. Ruberg, Ole B. Suhr, Mathew S. Maurer, Jose Nativi-Nicolau, Candida Cristina Quarta, Claudio Rapezzi, Ronald Witteles, Giampaolo Merlini
Publikováno v:
BMC Family Practice, Vol 21, Iss 1, Pp 1-12 (2020)
Abstract Background Transthyretin amyloidosis (also known as ATTR amyloidosis) is a systemic, life-threatening disease characterized by transthyretin (TTR) fibril deposition in organs and tissue. A definitive diagnosis of ATTR amyloidosis is often a
Externí odkaz:
https://doaj.org/article/78acd23bfad24bcdb52811fe1e3f573a
Autor:
Harvey, Ellen M., Freeman, Daniel, Wright, Andi, Bath, Jennifer, Peters, V. Kristen, Meadows, Gary, Hamill, Mark E., Flinchum, Misty, Shaver, Katherine H., Collier, Bryan R.
Publikováno v:
In Clinical Simulation in Nursing May 2019 30:7-15
Autor:
Nisha Arenja, Florian Andre, Johannes H. Riffel, Fabian aus dem Siepen, Ute Hegenbart, Stefan Schönland, Arnt V. Kristen, Hugo A. Katus, Sebastian J. Buss
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 21, Iss 1, Pp 1-12 (2019)
Abstract Background The differentiated assessment of functional parameters besides morphological changes is essential for the evaluation of prognosis in systemic immunoglobulin light chain (AL) amyloidosis. Methods Seventy-four subjects with AL amylo
Externí odkaz:
https://doaj.org/article/a154de66cea54fd68ce341656e91dced
Autor:
Peters, V. Kristen, Harvey, Ellen M., Wright, Andi, Bath, Jennifer, Freeman, Dan, Collier, Bryan
Publikováno v:
In Journal of Emergency Nursing January 2018 44(1):19-25
Autor:
Tobias Dittrich, Axel Benner, Christoph Kimmich, Fabian aus dem Siepen, Kaya Veelken, Arnt V. Kristen, Tilmann Bochtler, Hugo A. Katus, Carsten Müller-Tidow, Ute Hegenbart, Stefan O. Schönland
Publikováno v:
Haematologica, Vol 104, Iss 7 (2019)
Systemic light chain amyloidosis is a rare and life-threatening disorder, for which accurate risk stratification is crucial. Current cardiac staging systems (MAYO2004, MAYO3b, and MAYO2012) are mainly based on biomarkers, which have uncertain reliabi
Externí odkaz:
https://doaj.org/article/d860048752b849c8924dbd8d91ff72af
Autor:
Florian Andre, Arnt V. Kristen, Grigorios Korosoglou, Sorin Giusca, Norbert Frey, Peter Nunninger, Fabian aus dem Siepen
Publikováno v:
Vascular Health and Risk Management
Among non-ischemic cardiomyopathies, cardiac amyloidosis is one of the most common, being caused by extracellular depositions of amyloid fibrils in the myocardium. Two main forms of cardiac amyloidosis are known so far, including 1) light-chain (AL)